Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Sells $18,415.00 in StockZolmax • about 2 months agoEnliven Therapeutics, Inc. (NASDAQ:ELVN Get Free Report) Director Richard A. Heyman sold 1,270 shares of the firms stock in a transaction dated Tuesday, March 19th. The shares were...